Sabiedrība ar ierobežotu atbildību "pharm & med"
Copy
Copy
CopyRegistry data
Legal status
Company ID
CopyVAT code
CopyIncorporation date
Paid share capital
Registered share capital
Contacts
Company registration address
Copy
Website
-Latest events
from (18/11/2021)
2025-04-02
Change in beneficial owners2025-04-02
Change in members2024-01-19
Change in members2024-01-19
Unidentified type of changeSuspensions
No suspension
Register and unlock the potential of dataReliability
Register and check the change of employees’ number over the years
Number of employees
5Debts
0.00 €
0 €* during past year
Register and check if company had lawsuits over the years
Lawsuits as defendant
0
Credit limit
***** €
Turnover
2-5 M €
+18.95 %Business linkages
6Linkages with other companies
Financial ratios
Net Profit (€)
257,999
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Enjoy unlimited use
with Freemium unlimitedNet Profit (€)
257,999EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimitedFinancial statement report
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| 2023 |
|---|
| 2,368,434 |
| 473,687 |
| 72,726 |
| 50,747 |
| 10,149 |
| 57.38 |
| 2.14 |
| 1,029,818 |
| 354,875 |
| 214,030 |
| 1,170,663 |
| 2024 |
|---|
| 2,893,348 |
| 578,670 |
| 216,853 |
| 184,934 |
| 36,987 |
| 65.17 |
| 6.39 |
| 1,091,622 |
| 562,269 |
| 139,758 |
| 1,514,133 |
| 2025 |
|---|
| 3,441,554 |
| 688,311 |
| 262,553 |
| 257,999 |
| 51,600 |
| 66.40 |
| 7.50 |
| 1,342,358 |
| 651,845 |
| 125,147 |
| 1,869,056 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 3,441,554 |
| 688,311 |
| 262,553 |
| 257,999 |
| 51,600 |
| 66.40 |
| 7.50 |
| 1,342,358 |
| 651,845 |
| 125,147 |
| 1,869,056 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
3,441,554 €
19 % *
Sales per employee (€)
688,311 €19 % *
Profit before tax (€)
262,553 €21 % *
Net Profit (€)
257,999 €40 % *
Profit per employee (€)
51,600 €40 % *
Total profitability (%)
66.40 %1.89 % *
Net profitability (%)
7.50 %17.37 % *
Equity (€)
1,342,358 €23 % *
Amounts Payable And Liabilities (€)
651,845 €
16 % *
Non-current Assets (€)
125,147 €
-10 % *
Current Assets (€)
1,869,056 €23 % *
Credit history
No. of unpaid debts
0
Largest debt
VID
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
VID
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source  | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Legal proceedings
Defendant
(0)
Plaintiff
(0)
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
Public data
Data source | Information | Additional data |
|---|---|---|
 | Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2022 | Total amount: 212,710 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2021 | Total amount: 249,740 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2020 | Total amount: 185,810 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2019 | Total amount: 168,420 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2018
| No data provided by the national tax authority |
Similar companies
Category:
Wholesale of pharmaceutical products and medical suppliesComp. code:
40203653169Reg. date:
02/06/2025Turnover:
-No. of employees:
3Category:
Wholesale of pharmaceutical products and medical suppliesComp. code:
40203537360Reg. date:
02/02/2024Turnover:
-No. of employees:
3Category:
Wholesale of pharmaceutical products and medical suppliesComp. code:
40203444643Reg. date:
30/11/2022Turnover:
-No. of employees:
3Category:
Wholesale of pharmaceutical products and medical suppliesComp. code:
50203425451Reg. date:
09/09/2022Turnover:
-No. of employees:
3Category:
Wholesale of pharmaceutical products and medical suppliesComp. code:
40203409578Reg. date:
28/06/2022Turnover:
-No. of employees:
3Frequently Asked Questions
What is the current status of Sabiedrība ar ierobežotu atbildību "pharm & med"?
Sabiedrība ar ierobežotu atbildību "pharm & med" is currently Registered. It was registered on 06/07/2012.
What is Sabiedrība ar ierobežotu atbildību "pharm & med" registered address?
Sabiedrība ar ierobežotu atbildību "pharm & med" registered address is Dzelzavas iela 120Z, Rīga, LV-1021.
What is Sabiedrība ar ierobežotu atbildību "pharm & med" activity?
Sabiedrība ar ierobežotu atbildību "pharm & med" operates in Wholesale of pharmaceutical products and medical supplies (46.46 - NACE 2.1).
How many employees does Sabiedrība ar ierobežotu atbildību "pharm & med" have?
Sabiedrība ar ierobežotu atbildību "pharm & med" has 5 employees (2025).
Is Sabiedrība ar ierobežotu atbildību "pharm & med" a reliable company?
Sabiedrība ar ierobežotu atbildību "pharm & med" Pre-Score* rating is A, which indicates the highest level of reliability.
* The credit score is calculated based on financial data, payment history, and other risk indicators.What is the annual turnover of Sabiedrība ar ierobežotu atbildību "pharm & med"?
Sabiedrība ar ierobežotu atbildību "pharm & med" reported a turnover of 3,441,554 EUR in 2025.
Does Sabiedrība ar ierobežotu atbildību "pharm & med" have any current state debt?
Sabiedrība ar ierobežotu atbildību "pharm & med" currently has no outstanding state debt.